Skip to main navigation
Skip to search
Skip to main content
Taipei Medical University Home
Help & FAQ,
Link opens in a new tab
English
中文
Search content at Taipei Medical University
Home
Profiles
Research units
Projects
Research output
Datasets
Activities
Low Incidence of Malignancy after Heart Transplantation in Taiwan
Y. J. Wang
, N. H. Chi
, N. K. Chou
, S. C. Huang
, C. H. Wang
, I. H. Wu
, H. Y. Yu
, Y. S. Chen
, C. I. Tsao
, C. T. Shun
,
J. T. Tsai
, S. S. Wang
Department of Radiology
Graduate Institute of Clinical Medicine
Taipei Medical University Shuang Ho Hospital
Research output
:
Contribution to journal
›
Article
›
peer-review
4
Link opens in a new tab
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Low Incidence of Malignancy after Heart Transplantation in Taiwan'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Pharmacology, Toxicology and Pharmaceutical Science
Skin Cancer
100%
Comorbidity
100%
Malignant Neoplasm
66%
Median Survival Time
66%
Overall Survival
66%
Nonhodgkin Lymphoma
66%
Survival Rate
33%
Lung Cancer
33%
Leporidae
33%
Squamous Cell Carcinoma
33%
Steroids
33%
Calcineurin Inhibitor
33%
Ciclosporin
33%
Immunosuppressive Agent
33%
Basal Cell Carcinoma
33%
Mycophenolate Mofetil
33%
Squamous Cell Lung Carcinoma
33%
Congestive Cardiomyopathy
33%
Everolimus
33%
Ischemic Cardiomyopathy
33%
Azathioprine
33%
Cancer Staging
33%
Tacrolimus
33%
Keratoacanthoma
33%
Globulin
33%
Medicine and Dentistry
Cancer
100%
Heart Transplantation
100%
Skin Cancer
21%
Comorbidity
21%
Malignant Neoplasm
14%
Overall Survival
14%
Non-Hodgkin Lymphoma
14%
Median Survival Time
14%
Survival Rate
7%
Lung Cancer
7%
Prognostic Factor
7%
Cell Cycle
7%
Squamous Cell Carcinoma
7%
Dilated Cardiomyopathy
7%
Cancer Staging
7%
Kaplan Meier Method
7%
Immunosuppressive Treatment
7%
Univariate Analysis
7%
Cyclosporine
7%
Calcineurin Inhibitor
7%
Basal-Cell Carcinoma
7%
Globulin
7%
Mycophenolate Mofetil
7%
Heart Graft
7%
Azathioprine
7%
Ischemic Cardiomyopathy
7%
Squamous Cell Lung Carcinoma
7%
Everolimus
7%
Keratoacanthoma
7%
Thymocyte
7%
Tacrolimus
7%
Independent Factor
7%
Multivariate Analysis
7%
Steroid
7%
Immunology and Microbiology
Heart Transplantation
100%
Comorbidity
33%
Lung
22%
Squamous Cell
22%
Overall Survival
22%
Median Survival Time
22%
Survival Rate
11%
Leporidae
11%
Ciclosporin
11%
Immunosuppressive Therapy
11%
Basal Cell
11%
Thymocyte
11%
Tacrolimus
11%
Everolimus
11%
Azathioprine
11%
Cell Cycle
11%
Cancer Staging
11%
Globulin
11%
Steroid
11%
Mycophenolate Mofetil
11%
Nursing and Health Professions
Everolimus
11%
Ischemic Cardiomyopathy
11%
Keratoacanthoma
11%